539
Views
24
CrossRef citations to date
0
Altmetric
Review

Hashimoto’s thyroiditis: TGAb, TPOAb, TRAb and recovery from hypothyroidism

&
Pages 221-237 | Published online: 10 Jan 2014

References

  • Hashimoto H. Zur Kenntniss der lymphomatosen Veranderung der Schilddruse (struma lymphomatosa). Arch. Klin. Chir.97, 219–248 (1912).
  • Jensen EA, Petersen PH, Blaabjerg O et al. Establishment of reference distributions and decision values for thyroid antibodies against thyroid peroxidase (TPOAb), thyroglobulin (TgAb) and the thyrotropin receptor (TRAb). Clin. Chem. Lab. Med.44, 991–998 (2006).
  • Nagata K, Takasu N, Akamine H et al. Urinary iodine and thyroid antibodies in Okinawa, Yamagata, Hyogo, and Nagano, Japan: the differences in iodine intake do not affect thyroid antibody positivity. Endocr. J.45, 797–803 (1998).
  • Takasu N, Yamada T, Katakura M et al. Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto’s thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3´,5´-monophosphate responses/cell growth by immunoglobulins. J. Clin. Endocrinol. Metab.64, 239–245 (1987).
  • Surks MI, Ortiz E, Daniels GH et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA291, 228–238, (2004).
  • Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr. Rev.29(1), 76–131 (2007).
  • Okamura K, Nakashima T, Ueda K et al. Thyroid disorders in the general population of Hisayama Japan, with special reference to prevalence and sex differences. Int. J. Epidemiol.16, 545–549 (1987).
  • Bjoro T, Holmen J, Krüger O et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur. J. Endocrinol.143, 639–647 (2000).
  • Gordin A, Maatela J, Miettinen A et al. Serum thyrotrophin and circulating thyroglobulin and thyroid microsomal antibodies in a Finnish population. Acta Endocrinol.90, 33–42 (1979).
  • Tunbridge WM, Evered DC, Hall R et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin. Endocrinol. (Oxford)7, 481–493 (1977).
  • Akamine H, Takasu N, Komiya I et al. Association of HTLV-I with autoimmune thyroiditis in patients with adult T-cell leukaemia (ATL) and in HTLV-I carriers. Clin. Endocrinol. (Oxford)45, 461–466 (1996).
  • Sugenoya A, Itoh N, Kasuga Y et al. Histopathological features of atrophic thyroiditis with blocking type-TSH binding inhibitor immunoglobulins. Endocr. J.42, 277–281 (1995).
  • Brix TH, Kyvik KO, Hegedus L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J. Clin. Endocrinol. Metab.85, 536–539 (2000).
  • Ringold DA, Nicoloff JT, Kesler M et al. Further evidence for a strong genetic influence on the development of autoimmune thyroid disease: the California twin study. Thyroid12, 647–653 (2002).
  • Tandon N, Zhang L, Weetman AP. HLA associations with Hashimoto’s thyroiditis. Clin. Endocrinol. (Oxford)34, 383–386 (1991).
  • Mori T, Akamizu T, Kosugi S et al. Recent progress in TSH receptor studies with a new concept of ‘autoimmune TSH receptor disease’. Endocr. J.41, 1–11 (1994).
  • Roman SH, Greenberg D, Rubinstein P et al. Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. J. Clin. Endocrinol. Metab.74, 496–503 (1992).
  • Terauchi M, Yanagawa T, Ishikawa N et al. Interactions of HLA-DRB4 and CTLA-4 genes influence thyroid function in Hashimoto’s thyroiditis in Japanese population. J. Endocrinol. Invest.26, 1208–1212 (2003).
  • Lorini R, Gastaldi R, Traggiai C et al. Hashimoto’s thyroiditis. Pediatr. Endocrinol. Rev.1(Suppl. 2), 205–211 (2003).
  • Noble SE, Leyland K, Findlay CA et al. School based screening for hypothyroidism in Down’s syndrome by dried blood spot TSH measurement. Arch. Dis. Child.82, 27–31 (2000).
  • Bournaud C, Orgiazzi JJ. Iodine excess and thyroid autoimmunity. J. Endocrinol. Invest.26(2 Suppl.), 49–56 (2003).
  • Takasu N, Handa Y, Kawaoi A et al. Effects of iodide on thyroid follicle structure and electrophysiological potentials of cultured thyroid cells. Endocrinology117, 71–76 (1985).
  • Markou K, Georgopoulos N, Kyriazopoulou V et al. Iodine-induced hypothyroidism. Thyroid11, 501–510 (2001).
  • Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocr. Rev.14, 107–120 (1993).
  • Takasu N, Ikema T, Komiya I et al. Forty-year observation of 280 Japanese patients with congenital rubella syndrome. Diabetes Care28, 2331–2332 (2005).
  • Vanderpump MP, Tunbridge WM. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid12, 839–847 (2002).
  • Dang AH, Hershman JM. Lithium-associated thyroiditis. Endocr. Pract.8, 232–236 (2002).
  • Mazokopakis EE, Chatzipavlidou V. Hashimoto’s thyroiditis and the role of selenium. Current concepts. Hell. J. Nucl. Med.10, 6–8 (2007).
  • Mazokopakis EE, Papadakis JA, Papadomanolaki MG et al. Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto’s thyroiditis. Thyroid17, 609–612 (2007).
  • Manji N, Carr-Smith JD, Boelaert K et al. Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J. Clin. Endocrinol. Metab.91, 4873–4880 (2006).
  • Ansar Ahmed S, Young PR, Penhale WJ. The effects of female sex steroids on the development of autoimmune thyroiditis in thymectomized and irradiated rats. Clin. Exp. Immunol.54, 351–358 (1983).
  • Carella C, Mazziotti G, Amato G et al. Interferon-a-related thyroid disease: pathophysiological, epidemiological, and clinical aspects. J. Clin. Endocrinol. Metab.89, 3656–3661 (2004).
  • Corapçioglu D, Tonyukuk V, Kiyan M et al. Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies. Thyroid12, 613–617 (2002).
  • Martino E, Bartalena L, Bogazzi F et al. The effects of amiodarone on the thyroid. Endocr. Rev.22, 240–254 (2001).
  • Rose NR, Bonita R, Burek CL. Iodine: an environmental trigger of thyroiditis. Autoimmun. Rev.1, 97–103 (2002).
  • Van Wyk JJ, Arnold MB et al. The effects of a soybean product on thyroid function in humans. Pediatrics24, 752–760 (1959).
  • Pinchera A, MacGillivray MH, Crawford JD et al. Thyroid refractoriness in an athyreotic cretin fed soybean formula. N. Engl. J. Med.265, 83–87 (1965).
  • Yamada T. Effect of fecal loss of thyroxine on pituitary-thyroid feedback control in the rat. Endocrinology82, 327–332 (1968).
  • Chistiakov DA. Immunogenetics of Hashimoto’s thyroiditis. J. Autoimmune Dis.2, 1 (2005).
  • Freeman GJ, Long AJ, Iwai Y et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med.192, 1027–1034 (2000).
  • Carlé A, Laurberg P, Knudsen N et al. Thyroid peroxidase and thyroglobulin auto-antibodies in patients with newly diagnosed overt hypothyroidism. Autoimmunity39, 497–503 (2006).
  • LaFranchi S. Congenital hypothyroidism: etiologies, diagnosis, and management. Thyroid9, 735–740 (1999).
  • Matsuura N, Yamada Y, Nohara Y et al. Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins. N. Engl. J. Med.303, 738–741 (1980).
  • Takasu N, Mori T, Koizumi Y et al. Transient neonatal hypothyroidism due to maternal immunoglobulins that inhibit thyrotropin-binding and post-receptor processes. J. Clin. Endocrinol. Metab.59, 142–146 (1984).
  • Wolff, J, Chaikoff, IL. Plasma inorganic iodide as a homeostatic regulator of thyroid function. J. Biol. Chem.174, 555–564 (1948).
  • Eng PH, Cardona GR, Fang SL et al. Escape from the acute Wolff–Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology140, 3404–3410 (1999).
  • Martino E, Safran M, Aghini-Lombardi F et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann. Intern. Med.101, 28–34 (1984).
  • Martino E, Aghini-Lombardi F, Bartalena L et al. Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid autoimmune disease. Arch. Intern. Med.154, 2722–2726 (1994).
  • Martino E, Aghini-Lombardi F, Mariotti S et al. Amiodarone: a common source of iodine-induced thyrotoxicosis. Horm. Res.26, 158–171 (1987)
  • Martino E, Aghini-Lombardi F, Mariotti S et al. Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. Clin. Endocrinol. (Oxford)26, 227–237 (1987).
  • Hydovitz JD. Occurrence of goiter in an infant on a soy diet. N. Engl. J. Med.262, 351–353 (1960).
  • Shepard TH, Pyne GE, Kirschvink JF et al. Soybean goiter. N. Engl. J. Med262, 1099–1103 (1960).
  • Ripp JW. Soybean-induced goiter. Am. J. Dis. Child.102, 106–109 (1961).
  • Labib M, Gama R, Wright J et al. Dietary maladvice as a cause of hypothyroidism and short stature. Br. Med. J.293, 232–233 (1989).
  • Chorazy PA, Himelhoch S, Hopwood NJ et al. Persistent hypothyroidism in an infant receiving a soy formula: case report and review of the literature. Pediatrics96, 148–150 (1995).
  • Jabbar MA, Larrea J, Shaw RA. Abnormal thyroid function tests in infants with congenital hypothyroidism: the influence of soy-based formula. J. Am. Coll. Nutr.16, 280–282 (1997).
  • Fort P, Moses N, Fasano M et al. Breast and soy-formula feedings in early infancy and the prevalence of autoimmune thyroid disease in children. J. Am. Coll. Nutr.9, 164–167 (1990).
  • Ishizuki Y, Hirooka Y, Murata Y et al. The effects on the thyroid gland of soybeans administered experimentally in healthy subjects. Nippon Naibunpi Gakkai Zasshi67, 622–629 (1991).
  • Takasu N, Yamada T, Takasu M et al. Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N. Engl. J. Med.326, 513–518 (1992).
  • Takasu N, Oshiro C, Akamine H et al. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves’ patients and in 686 normal subjects. J. Endocrinol. Invest.20, 452–461 (1997).
  • Takasu N, Yamashiro K, Ochi Y et al. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves’ patients with hyperthyroidism. Horm. Metab. Res.33, 232–237 (2001).
  • Takasu N, Kamijo K, Sato Y et al. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves’ disease. Clin. Exp. Pharmacol. Physiol.31, 314–319 (2004).
  • Cooper DS. Clinical practice. Subclinical hypothyroidism. N. Engl. J. Med.345, 260–265 (2001)
  • Huber G, Staub JJ, Meier C et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J. Clin. Endocrinol. Metab.87, 3221–3226 (2002).
  • Braverman LE, Utiger RD et al. Thyroid diseases: hypothyroidism. In: Werner and Ingbar’s The Thyroid (8th Edition). Braverman LE, Utiger RD (Eds). Lippincott Williams and Wilkins, PA, USA 717–858 (2000).
  • Hennessey JV, Evaul JE, Tseng YC et al. L-thyroxine dosage: a reevaluation of therapy with contemporary preparations. Ann. Intern. Med.105, 11–15 (1986).
  • Betterle C, Volpato M, Greggio AN et al. Type 2 polyglandular autoimmune disease (Schmidt’s syndrome). J. Pediatr. Endocrinol. Metab.9(Suppl. 1), 113–123 (1996).
  • Graves L 3rd, Klein RM, Walling AD. Addisonian crisis precipitated by thyroxine therapy: a complication of type 2 autoimmune polyglandular syndrome. South Med. J.96, 824–827 (2003).
  • Hak AE, Pols HA, Visser TJ et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann. Intern. Med.132, 270–278 (2000).
  • Casey BM, Dashe JS, Wells CE et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet. Gynecol.105, 239–245 (2005).
  • Setian NS. Hypothyroidism in children: diagnosis and treatment. J. Pediatr. (Rio J.)83(5 Suppl.), S209–S216 (2007).
  • Papi G, Uberti ED, Betterle C et al. Subclinical hypothyroidism. Curr. Opin. Endocrinol. Diabetes Obes.14, 197–208 (2007).
  • De Groot LJ. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J. Clin. Endocrin. Metab.84, 151–164 (1999).
  • Chopra IJ. Clinical review 86. Euthyroid sick syndrome: is it a misnomer? J. Clin. Endocrinol. Metab.82, 329–334 (1997).
  • Pingitore A, Landi P, Raciti M et al. Low-T3 syndrome; a strong prognostic predictor of death in patients with heart disease. Circulation107, 708–713 (2003).
  • Takasu N, Komiya I, Asawa T et al. Test for recovery from hypothyroidism during thyroxine therapy in Hashimoto’s thyroiditis. Lancet336(8723), 1084–1086 (1990).
  • Takasu N, Komiya I, Nagasawa Y et al. Exacerbation of autoimmune thyroid dysfunction after unilateral adrenalectomy in patients with Cushing’s syndrome due to an adrenocortical adenoma. N. Engl. J. Med.322, 1708–1712 (1990).
  • Takasu N, Ohara N, Yamada T et al. Development of autoimmune thyroid dysfunction after bilateral adrenalectomy in a patient with Carney’s complex and after removal of ACTH-producing pituitary adenoma in a patient with Cushing’s disease. J. Endocrinol. Invest.16, 697–702 (1993).
  • Amino N, Mori H, Iwatani Y et al. High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. N. Engl. J. Med.306, 849–852 (1982).
  • Sato K, Okamura K, Hirata T et al. Immunological and chemical types of reversible hypothyroidism; clinical characteristics and long-term prognosis. Clin. Endocrinol. (Oxford)45, 519–528 (1996).
  • Takasu N. [Effect of iodine-containing gargling solution on thyroid function.] Nippon Iji Shinpou.4041, 93–94 (2001).
  • Tajiri J, Higashi K, Morita M et al. Studies of hypothyroidism in patients with high iodine intake. J. Clin. Endocrinol. Metab.63, 412–417 (1986).
  • Sato K, Ohmori T, Shiratori K et al. Povidone iodine-induced overt hypothyroidism in a patient with prolonged habitual gargling: urinary excretion of iodine after gargling in normal subjects. Intern. Med.46, 391–395 (2007).
  • Takasu N, Takara M, Komiya I. Rifampin-induced hypothyroidism in patients with Hashimoto’s thyroiditis. N. Engl. J. Med.352, 518–519 (2005).
  • Takasu N, Kinjou Y, Kouki T et al. Rifampin-induced hypothyroidism. J. Endocrinol. Invest.29, 645–649 (2006).
  • Smit JW, Stokkel MP, Pereira AM et al. Bexarotene-induced hypothyroidism: bexarotene stimulates the peripheral metabolism of thyroid hormones. J. Clin. Endocrinol. Metab.92, 2496–2499 (2007).
  • McDonnell ME, Braverman LE, Bernardo J. Hypothyroidism due to ethionamide. N. Engl. J. Med.352, 2757–2759 (2005).
  • Takasu N, Yamada T, Sato A et al. Graves’ disease following hypothyroidism due to Hashimoto's disease: studies of eight cases. Clin. Endocrinol. (Oxford)33, 687–698 (1990).
  • Tomer Y, Ban Y, Concepcion E et al. Common and unique susceptibility loci in Graves’ and Hashimoto’s diseases: results of whole-genome screening in a data set of 102 multiplex families. Am. J. Hum. Genet.73, 736–747 (2003).
  • McLachlan SM, Nagayama Y, Pichurin PN et al. The link between Graves’ disease and Hashimoto’s thyroiditis: a role for regulatory T cells. Endocrinology148, 5724–5733 (2007).
  • Taddei S, Caraccio N, Virdis A et al. Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab.91, 5076–5082 (2006).
  • Lauritano EC, Bilotta AL, Gabrielli M et al. Association between hypothyroidism and small intestinal bacterial overgrowth. J. Clin. Endocrinol. Metab.92, 4180–4184 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.